1
Views
3
CrossRef citations to date
0
Altmetric
Review

Fetal growth restriction and maternal cardiac function

, &
Pages 119-127 | Published online: 10 Jan 2014

References

  • Bernstein I, Gabbe SG. Intrauterine growth restriction. In: Obstetrics: Normal and Problem Pregnancies. Gabbe SG, Niebyl JR, Simpson JL (Eds). Churchill Livingstone, NY, USA (1996).
  • McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N. Engl. J. Med.340, 1234–1238 (1999).
  • Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia36, 62–67 (1993).
  • Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet341, 938–941 (1993).
  • Resnik R, Creasy RK. Intrauterine growth restriction. In: Maternal–Fetal Medicine: Principles and Practice (5th Edition). Creasy RK, Resnik R, Iams JD (Eds). Saunders, PA, sUSA, (2004).
  • Berghella V. Prevention of recurrent fetal growth restriction. Obstet. Gynecol.110, 904–912 (2007).
  • Khong TY, DeWolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small for gestational age infants. Br. J. Obstet. Gynaecol.93, 1049–1059 (1986).
  • Matijevic R, Kurjak A, Hafner T. Terminal parts of uteroplacental circulation in pregnancy: assessment color/pulsed Doppler ultrasound. Ultrasound Rev. Obstet. Gynecol.1, 262–274 (2001).
  • Hitschold T, Weiss E, Beck T, Hunterfering H, Berle P. Low target birth weight or growth retardation? Umbilical Doppler flow velocity waveforms and histometric analysis of fetoplacental vascular tree. Am. J. Obstet. Gynecol.168, 1260–1264 (1993).
  • Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J.3, 2007–2018 (1989).
  • Fleming I, Busse R. NO: the primary EDRF. J. Mol. Cell. Cardiol.31, 5–14 (1999).
  • Ignarro LJ, Kadowitz PJ. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol. Toxicol.25, 171–191 (1985).
  • Payne JA, Alexander BT, Khalil RA. Reduced endothelial vascular relaxation in growth-restricted offspring of pregnant rats with reduced uterine perfusion. Hypertension.42, 768–774 (2003).
  • Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am. J. Physiol.136, H1060–H1065 (1989).
  • Poppas A, Shroff SG, Korcarz CE et al. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation95, 2407–2415 (1997).
  • Valensise H, Novelli GP, Vasapollo B et al. Maternal cardiac systolic and diastolic function: relationship with uteroplacental resistances. A Doppler and echocardiographic longitudinal study. Ultrasound Obstet. Gynecol.15, 487–497 (2000).
  • Cappless EL, Clapp JF. Cardiovascular changes in the early phase of pregnancy. Am. J. Obstet. Gynecol.161, 1449–1453 (1989).
  • Mone SM, Sanders SP, Colan SD. Control mechanisms for physiological hypertrophy of pregnancy. Circulation94, 667–672 (1996).
  • Duvekot JJ, Cheriex EC, Pieters FAA, Menheere PPCA, Peeters LLH. Early-pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am. J. Obstet. Gynecol.169, 1382–1392 (1993).
  • Katz R, Karliner JS, Resink R. Effects of a natural overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation58, 434–441 (1978).
  • Kametas NA, McAuliffe F, Hancock J, Chambers J, Nicolaides KH. Maternal left ventricular mass and diastolic function during pregnancy. Ultrasound Obstet. Gynecol.18, 460–466 (2001).
  • Vered Z, Poler SM, Gibson P, Wlody D, Perez JE. Noninvasive detection of the morphologic and hemodynamic changes during normal pregnancy. Clin. Cardiol.24(4), 327–334 (1991).
  • Weissman NJ, Adelman GA. Systolic and diastolic function of the ventricles. In: Cardiac Imaging Secrets. Hanley & Belfus, PA, USA, 92–94 (2004).
  • Mabie WC, Di Sessa TG, Crocker LG, Sibai BM, Arheart KL. A longitudinal study of cardiac output in normal human pregnancy. Am. J. Obstet. Gynecol.170, 849–856 (1994).
  • Mesa A, Carlos J, Hernandez A et al. Left ventricular diastolic function in normal human pregnancy. Circulation9, 511–517 (1999).
  • Clapp JF, Capeless E. Cardiovascular function before, during and after the first and subsequent pregnancies. Am. J. Cardiol.11, 1469–1473 (1997).
  • Van Oppen ACC, Van Der Tweel, Alsbach GPJ, Heethaar RM, Bruinse HW. A longitudinal study of maternal hemodynamics during normal pregnancy. Obstet. Gynecol.88, 40–46 (1996).
  • Geva T, Mauer MB, Strinker L, Kirshow B, Pivarnik JM. Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am. Heart J.133, 53–59 (1997).
  • Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br. Heart J.68, 540–543 (1992).
  • Vergani P, Roncaglia N, Andreotti C et al. Prognostic value of uterine artery Doppler velocimetry in growth-restricted fetuses delivered near term. Am. J. Obstet. Gynecol.4, 932–936 (2002).
  • Campbell S, Black RS, Lees C, Armstrong V, Peacock JL. Doppler Ultrasound of the maternal uterine arteries: disappearance of abnormal waveforms and relation to birthweight and pregnancy outcome. Acta Obstet. Gynecol. Scand.8, 631–634 (2000).
  • Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia, an endothelial cell disorder. Am. J. Obstet. Gynecol.161, 1200–1204 (1989).
  • Taylor RN, Heilbron DC, Roberts JM. Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy. Am. J. Obstet. Gynecol.163, 1839–1844 (1990).
  • Roberts JM, Taylor RM, Goldfein A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am. J. Hypertens.4, 700–708 (1991).
  • Vasapollo B, Valensise H, Novelli GP et al. Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction. Ultrasound Obstet. Gynecol.20, 452–457 (2002).
  • Duvekot JJ, Cheriex EC, Pieters FA, Peeters LH. Severely impaired fetal growth is preceded by maternal hemodynamic maladaptation in very early pregnancy. Acta Obstet. Gynecol. Scand.74, 693–697 (1995).
  • Gibson HM. Plasma volume and glomerular filtration rate in pregnancy and their relation to differences in fetal growth. J. Obstet. Gynaecol. Br. Commonw.80, 1067–1074 (1973).
  • Goodlin RC, Quaife MA, Dirksen JW. The significance diagnosis and treatment of maternal hypovolemia as associated with fetal–maternal illness. Semin. Perinatol.5, 163–174 (1981).
  • Gallery EDM, Hunyor SN, Gyorv AZ. Plasma volume contraction: a significant factor in both pregnancy associated hypertension (preeclampsia) and chronic hypertension in pregnancy. QJM48, 593–602 (1979).
  • Di Donato M, Mori F, Barletta G, Dabizzi RP, Fantini F. Effect of dextran infusion on left atrial size in normal subjects. Cardiology69, 257–264 (1982).
  • Creasy RH, Barret CT, DeSwiet M, Kahanpaa KV, Rudolph AM. Experimental intrauterine growth retardation in the sheep. Am. J. Obstet. Gynecol.112, 566–573 (1972).
  • Nisell H, Lunell NO, Linde B. Maternal hemodynamics and impaired fetal growth in pregnancy-induced hypertension. Obstet. Gynecol.71, 163–166 (1988).
  • Veille GC, Morton MJ, Paul MS. Maternal left ventricular dimension in pregnancies complicated by fetal growth retardation. Obstet. Gynecol.78, 265–269 (1991).
  • Valensise H, Novelli GP, Vasapollo B et al. Maternal diastolic dysfunction and left ventricular geometry in gestational hypertension. Hypertension37, 1209–1215 (2001).
  • Hedberg E, Radberg C. Maternal heart volume and prematurity. Acta Obstet. Gynecol. Scand.41, 48–56 (1962).
  • Unnerus CE. Heart volume and prematurity. Acta Obstet. Gynecol. Scand.38, 340–351(1959).
  • Valensise H, Vasapollo B, Novelli GP, Pasqualetti P, Galante A, Arduini D. Maternal total vascular resistance: a key to identify uncomplicated gestational hypertension. Br. J. Obstet. Gynaecol.113, 1044–1052 (2006).
  • Novelli GP, Valensise H, Vasapollo B et al. Left ventricular concentric geometry as a risk factor in gestational hypertension. Hypertension41, 469–475 (2003).
  • Vasapollo B, Valensise H, Novelli GP, Altomare F, Galante A, Arduini D. Maternal cardiac function as a key to differentiate small for gestational age from fetal growth restriction. Ultrasound Obstet. Gynecol.24, 23–29 (2004).
  • Bamfo JEAK, Kametas NA, Chambers JB, Nicolaides KH. Maternal cardiac function in fetal growth-restricted and non-growth-restricted small-for-gestational age pregnancies. Ultrasound Obstet. Gynecol.29, 51–57 (2007).
  • Bamfo JEAK, Kametas NA, Turan O, Khaw A, Nicolaides KH. Maternal cardiac function in fetal growth restriction. Br. J. Obstet. Gynaecol.113, 784–791 (2006).
  • Valensise H, Vasapollo B, Novelli GP et al. Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in gestational hypertension complicated by fetal growth restriction with absent end diastolic flow of the umbilical artery. Ultrasound Obstet. Gynecol. (In press).
  • Baschat AA, Gembruch U, Harman CR. The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet. Gynecol.18, 571–577 (2001).
  • Hecher K, Campbell S, Snijders R, Nicolaides KH. Reference ranges for fetal venous Doppler and atrioventricular blood flow parameters. Ultrasound Obstet. Gynecol.4, 381–390 (1994).
  • Ferrazzi E, Bozzo M, Rigano S et al. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet. Gynecol.19, 140–146 (2002).
  • Bilardo CM, Stigter RH, Ville Y, Baez E, Visser GH, Hecher K. Monitoring of fetus with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet. Gynecol.18, 564–570 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.